title: A phase II study of vindesine plus etoposide in metastatic non-small cell lung cancer.
authors.forename: P S
authors.initials: PS
authors.lastname: Hupperets
authors.forename: G P
authors.initials: GP
authors.lastname: ten Velde
authors.forename: H
authors.initials: H
authors.lastname: Bron
authors.forename: L
authors.initials: L
authors.lastname: Schouten
authors.forename: G H
authors.initials: GH
authors.lastname: Blijham
mesh_terms: D000328:Adult; D000368:Aged; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D002289:Carcinoma, Non-Small-Cell Lung / Q000556:secondary*; D004341:Drug Evaluation; D005047:Etoposide / Q000008:administration & dosage; D006801:Humans; D008175:Lung Neoplasms / Q000556:secondary*; D008875:Middle Aged; D014751:Vindesine / Q000008:administration & dosage
chemical_list: D005047:Etoposide; D014751:Vindesine